drugset / Trial / NCT06732648

The Efficacy and Safety of HRS8179 in Severe Cerebral Edema Following Large Hemispheric Infarction

NCT06732648 ↗

Phase 2/3 Recruiting 725 enrolled Beijing Suncadia Pharmaceuticals Co., Ltd
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study is being conducted to evaluate the efficacy, and safety of HRS8179 injection in preventing and treating severe cerebral edema after large area cerebral infarction in the cerebral hemisphere

Timeline

Start
2025-02-07
Primary completion
2027-06
Completion
2027-09

Drugs

EvaluationDrugModalityDoseRoute
Subject HRS8179 Unknown — Intravenous

Indications